aTYR PHARMA INC - 8-K Filing
aTyr Pharma received a delisting notice from Nasdaq for failing to maintain the minimum bid price of $1.00 per share under Listing Rule 5550(a)(2). The company was granted an additional 180-day compliance period until November 30, 2026 and may use a reverse stock split if necessary. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing)
Tickers: $ATYR